Educational8 min read·

What is BPC-157? A Research Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. This overview covers its molecular structure, research history, and current scientific findings.

Overview

BPC-157 is a synthetic pentadecapeptide — a chain of fifteen amino acids — derived from a partial sequence of Body Protection Compound, a protein identified in human gastric juice. Its sequence is commonly written as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight near 1419 Da.

Unlike many peptides studied in laboratory settings, BPC-157 has drawn attention in the literature partly because of its reported stability in gastric acid, a property attributed to its parent protein's native environment. That stability makes it a convenient subject for in vitro and animal-model work, which is where nearly all published data on the compound originates.

Molecular characteristics

| Property | Value | | --- | --- | | Class | Synthetic pentadecapeptide | | Residues | 15 amino acids | | Approx. molecular weight | 1419 Da | | Typical form supplied | Lyophilized powder | | Solubility | Readily soluble in bacteriostatic or sterile water |

The peptide contains no cysteine residues, so it does not form the disulfide bridges that complicate handling of some other research peptides. In practice this simplifies reconstitution, though standard cold-chain and light-protection practices still apply.

Mechanisms studied in research settings

Published work on BPC-157 is predominantly preclinical. Investigators have examined several proposed mechanisms:

  • Angiogenic signalling. Several rodent studies report upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) and downstream nitric oxide pathways in tissue exposed to the peptide.
  • Fibroblast migration. In vitro work has examined effects on fibroblast outgrowth and adhesion, processes central to connective tissue models.
  • Nitric oxide system interaction. A recurring theme in the literature is interaction with NO synthesis pathways, studied both with NO donors and with inhibitors.
  • Gastrointestinal models. Given the compound's origin in gastric juice, a substantial share of early literature used gastrointestinal injury models.

It is important to frame all of this carefully. These are observations in controlled animal and cell-culture models. There is no established clinical evidence base in humans, and BPC-157 is not an approved therapeutic in the United States or elsewhere.

Current state of the literature

The BPC-157 literature is notable for two things: a relatively large volume of preclinical publications, and a heavy concentration of that output within a small number of research groups. For researchers evaluating the compound, that concentration is worth accounting for when assessing reproducibility. Independent replication across laboratories remains comparatively limited.

Areas that appear most frequently in published abstracts include connective tissue models, gastrointestinal mucosal models, and vascular studies. Reviews published in the last several years have generally concluded that the preclinical signal is interesting but that translation to human data has not occurred.

Handling and storage in the laboratory

BPC-157 is supplied as a lyophilized powder and is stable at room temperature for short transit periods. Once received:

  • Store the sealed lyophilized vial refrigerated at 2 to 8 degrees Celsius for short-term holding, or at minus 20 degrees Celsius or lower for extended storage.
  • After reconstitution, keep the solution refrigerated and protected from light.
  • Avoid repeated freeze-thaw cycles, which degrade peptide integrity. Aliquot if the working protocol requires multiple withdrawals.
  • Record the lot number against your experimental records so results can be traced back to a specific certificate of analysis.

What to verify before purchasing

Any peptide used in research is only as reliable as its documentation. Look for a batch-specific certificate of analysis showing HPLC purity — a threshold of at least 98 percent is a reasonable expectation — along with mass spectrometry confirming the expected molecular weight. A COA that is generic, undated, or not tied to a lot number does not tell you what is in the vial you received.

Research use only. This content is for educational and informational purposes related to scientific research. It is not medical advice and does not describe dosing or administration for human use. Products are sold for laboratory research by qualified professionals only.